TERN Terns Pharmaceuticals, Inc.
Price Chart
Executive Summary
Terns Pharmaceuticals' automatic shelf registration statement (S-3ASR) filed on December 9, 2025, became effective on May 7, 2026. This allows the company to offer and sell up to an undisclosed amount of common stock, preferred stock, debt securities, depositary shares, subscription rights, warrants, or units from time to time. The effectiveness creates a potential dilution overhang for existing shareholders, as the company can now conduct offerings at any time without further SEC review.
Actionable Insight
The shelf effectiveness gives Terns the flexibility to raise capital opportunistically. Monitor for prospectus supplements that would indicate an actual offering — any announced deal size above ~$100M could pressure the stock due to dilution. The cross-filing context shows this shelf was filed 150 days ago, so the effectiveness may simply be procedural, but the company's ability to tap the market at any time creates overhang.
Key Facts
- Effectiveness date: May 7, 2026
- Registration statement file number: 333-287092
- Shelf registration covers common stock, preferred stock, debt securities, depositary shares, subscription rights, warrants, and units
- Company qualifies as a well-known seasoned issuer (WKSI) under Rule 405
- No specific offering size, pricing, or terms disclosed in the effectiveness notice
- Prior S-3ASR filed on December 9, 2025, is the underlying registration
Financial Impact
Undisclosed — no offering size or pricing provided in the filing
Risk Factors
- Potential dilution from future offerings under the shelf
- No specific use of proceeds disclosed, creating uncertainty about capital allocation
- Biotech sector sensitivity to equity issuance — any announced offering could weigh on share price
Market Snapshot
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001530 |
| Document: 9999999995-26-001530-index.html | 9999999995-26-001530 |
| Document: 9999999995-26-001530.txt | 9999999995-26-001530 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 15, 2026
25d ago
|
15-12G
| $52.97 awaiting T+1 | awaiting T+1 | — | — |
|
May 8, 2026
4w ago
|
EFFECT
| $52.95 $52.95 | · 0.00% | ▼ −0.23% | — |
|
May 5, 2026
5w ago
|
8-K
| $52.95 $52.95 | · 0.00% | ▼ −1.38% | — |
|
May 5, 2026
5w ago
|
25-NSE
| $52.95 $52.95 | · 0.00% | ▲ +1.38% | — |
|
Apr 27, 2026
6w ago
|
8-K
| $52.95 $52.94 | ▼ −0.02% | ▲ +0.47% | — |
|
Apr 27, 2026
6w ago
|
Press Release
| $52.95 $52.94 | ▼ −0.02% | ▲ +0.47% | — |
|
Mar 25, 2026
10w ago
|
Press Release
| $52.86 $53.17 | ▲ +0.59% | ▲ +2.36% | — |
|
Feb 28, 2026
14w ago
|
Institutional Cluster
| $42.03 $41.51 | ▼ −1.24% | ▼ −0.32% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access